Difficult pseudoexon splicing prediction is addressed with SSOs that promote mature mRNA incorporation and modulate target-protein expression.
This case uses IGS-guided RNA binding and trans-splicing to replace harmful APOE4 RNA in neurons with beneficial RNA.
This case shows how 5′-modified nucleosides and nucleotides support nuclease resistance while simplifying industrial production.
Chemical modifications improve DMD oligonucleotide stability and cell penetration, supporting exon skipping and dystrophin restoration.
This case combines anti-TfR1 antibody delivery with DMPK-targeting oligonucleotides to address ineffective DM1 therapies in muscle cells.
A guide RNA, RNA-binding domain, and repair template improve targeted trans-splicing specificity and efficiency for transient RNA repair.
This case uses exon 6-targeting SM-ASOs to modulate soluble IL7R while preserving membrane-bound IL7R in autoimmune and cancer therapy.
This case combines cell-penetrating peptides and carbohydrate targeting to improve intracellular oligonucleotide delivery to liver cells.
This case uses antisense oligonucleotides to suppress the intron 22 cryptic exon and increase correctly spliced CFTR mRNA.